CLINICAL_TRIALS
trial_result
· 2018-10-05
Clinical Trial Update: Pilot Efficacy and Safety Study of AQX-1125 in Atopic Dermatitis [Phase 2]
Summary
Phase 2 pilot efficacy and safety study of AQX-1125 in Atopic Dermatitis completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aquinox Pharmaceuticals (Canada) Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2018-10-05